fluconazole has been researched along with Cardiovascular Diseases in 3 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Excerpt | Relevance | Reference |
---|---|---|
"The extent of potential pharmacokinetic drug-drug interactions affecting anticancer agents disposition has not been specifically investigated." | 1.35 | Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients. ( Beretz, L; Bergerat, JP; Lemachatti, J; Levêque, D, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shigemura, K | 1 |
Osawa, K | 1 |
Jikimoto, T | 1 |
Yoshida, H | 1 |
Hayama, B | 1 |
Ohji, G | 1 |
Iwata, K | 1 |
Fujisawa, M | 1 |
Arakawa, S | 1 |
Lemachatti, J | 1 |
Levêque, D | 1 |
Beretz, L | 1 |
Bergerat, JP | 1 |
Gori, T | 1 |
Dragoni, S | 1 |
Lisi, M | 1 |
Di Stolfo, G | 1 |
Sonnati, S | 1 |
Fineschi, M | 1 |
Parker, JD | 1 |
1 trial available for fluconazole and Cardiovascular Diseases
Article | Year |
---|---|
Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function.
Topics: Adult; Biomechanical Phenomena; Cardiovascular Diseases; Enzyme Inhibitors; Female; Fluconazole; Hum | 2008 |
2 other studies available for fluconazole and Cardiovascular Diseases
Article | Year |
---|---|
Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candida; Candida albicans; Candid | 2014 |
Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cardiovascular Diseases; Comorbidity; Cytochr | 2009 |